Novo Nordisk has agreed to buy Akero Therapeutics and its drug candidate for metabolic dysfunction-associated steatohepatitis (MASH) for $4.7 billion upfront, shortly after claiming FDA approval to ...
If you're an Android user, you likely have Gmail on your phone. It's one of those essential apps that many rely on every day for work and personal use. Other than Gmail, Android users have other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback